Immatics (IMTX) FCF Margin (2019 - 2025)

Immatics recorded quarterly FCF Margin of 291.96% in Q4 2025, up 65.28% quarter-over-quarter from 840.85% in Q3 2025, and down 12036.0% year-over-year from N/an in Q4 2024.

Immatics' FCF Margin history runs 7 years deep, the most recent figure standing at 291.96% for Q4 2025.

  • In Q4 2025, FCF Margin fell 12036.0% year-over-year to 291.96%; the TTM figure through Dec 2025 stood at 358.48% (down 22121.0% YoY), while the FY2025 annual figure was 352.36%, down 26139.0% from the prior year.
  • FCF Margin came in at 291.96% for Q4 2025 at Immatics, up from 840.85% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 285.75% in Q2 2022 to a low of 840.85% in Q3 2025.
  • A 5-year average of 199.88% and a median of 165.34% in 2024 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin soared 64416 bps in 2022 and plunged 69358 bps in 2025, its largest moves.
  • Immatics' FCF Margin stood at 149.0% in 2021, then grew by 28 bps to 107.78% in 2022, then jumped by 256 bps to 168.16% in 2023, then sank by 202 bps to 171.61% in 2024, then plunged by 70 bps to 291.96% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods registered 291.96%, 840.85%, and 794.32% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 Immatics 1.80 Bn 1.80 Bn - -291.96%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -291.96%
Sep 30, 2025 -840.85%
Jun 30, 2025 -794.32%
Mar 31, 2025 -167.53%
Dec 31, 2024 -171.61%
Sep 30, 2024 -147.28%
Jun 30, 2024 -163.14%
Mar 31, 2024 -77.41%
Dec 31, 2023 168.16%
Sep 30, 2023 -405.40%
Jun 30, 2023 18.25%
Mar 31, 2023 -198.02%
Dec 31, 2022 -107.78%
Sep 30, 2022 -151.18%
Jun 30, 2022 285.75%
Mar 31, 2022 105.48%
Dec 31, 2021 -149.00%
Sep 30, 2021 -333.94%
Jun 30, 2021 -358.41%
Mar 31, 2021 -217.37%
Dec 31, 2020 -361.16%
Sep 30, 2020 -391.02%
Jun 30, 2020 -205.28%
Mar 31, 2020 -128.81%
Dec 31, 2019 669.23%
Sep 30, 2019 941.04%